Small Molecule Scaffold Based Antimalarial Research Against Plasmodium falciparum: A Pharmaceutical and AI Supported Perspective

Abstract

Malaria caused by Plasmodium falciparum remains a serious global health threat, entailing to emergence of resistance to almost existing antimalarial therapeutics. This situation emphasizes the need for the discovery of novel therapeutic agents with improved efficacy and safety. In recent years small molecular scaffolds have attracted significant attention in antimalarial drug discovery owing to their rational structure and quintessential interaction with the parasite protein. The present research focuses on the pharmaceutical and biological evaluation of small molecule scaffolds as potential therapeutics against Plasmodium falciparum. Such scaffold provides a suitable framework for rational drug design, enabling systematic structural modification to enhance antimalarial activity, selectivity and pharmacokinetics properties. AI enabled techniques such as structure activity relationship (SAR) analysis, predictive data modeling and scaffold prioritization can assist researchers in interpreting biological data and guiding early- stage drug development. These approaches do not essentially replace human intervention, which validates the real experimental procedure of drug discovery expedition. The integration of pharmaceutical research, biological evaluation and AI enabled analysis offers a promising strategy for the development of effective small molecule therapeutics against Plasmodium falciparum.